[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Page 54263]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19088]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-718 (Fifth Review)]


Glycine From China

Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping duty order on glycine from 
China would be likely to lead to continuation or recurrence of material 
injury to an industry in the United States within a reasonably 
foreseeable time.\2\
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
    \2\ Commissioner Amy A. Karpel not participating.
---------------------------------------------------------------------------

Background

    The Commission instituted this review on January 3, 2022 (87 FR 
112) and determined on April 8, 2022 that it would conduct an expedited 
review (87 FR 44422, July 26, 2022).
    The Commission made this determination pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determination in this review on August 30, 2022. The views of the 
Commission are contained in USITC Publication 5347 (August 2022), 
entitled Glycine from China: Investigation No. 731-TA-718 (Fifth 
Review).

    By order of the Commission.

    Issued: August 30, 2022.
Katherine Hiner,
Acting Secretary to the Commission.
[FR Doc. 2022-19088 Filed 9-1-22; 8:45 am]
BILLING CODE 7020-02-P